Dr. Oliver Grundmann is an Assistant Dean for Lifelong Learning, Clinical Professor, and Director in the Department of Medicinal Chemistry at the University of Florida College of Pharmacy. He received a bachelor’s degree in pharmacy and a European pharmacist license from the University of Münster, Germany, in 2004 before beginning his graduate studies at the University of Florida. While continuing his Ph.D. in Pharmaceutical Sciences, he worked for the Forensic Science program after graduating with a master’s degree in Forensic Toxicology and a minor in Statistics. In September 2023, he assumed the role of Assistant Dean of Lifelong Learning in the University of Florida College of Pharmacy. His research interests include the search for new treatment options from natural products for central nervous system and gastrointestinal diseases such as anxiety and depressive disorders, as well as irritable bowel syndrome and cancers of the gastrointestinal tract. He served as President-Elect of the American College of Clinical Pharmacology from 2022 to 2024 and as President from 2024 to 2026. He received the Elizabeth Wood Dunlevie Honors Term Professorship Award from the University of Florida Honors Program for 2025–2026.
Dr. Oliver Grundmann is an Assistant Dean for Lifelong Learning, Clinical Professor, and Director in the Department of Medicinal Chemistry at the University of Florida College of Pharmacy. He received a bachelor’s degree in pharmacy and a European pharmacist license from the University of Münster, Germany, in 2004 before beginning his graduate studies at the University of Florida. While continuing his Ph.D. in Pharmaceutical Sciences, he worked for the Forensic Science program after graduating with a master’s degree in Forensic Toxicology and a minor in Statistics. In September 2023, he assumed the role of Assistant Dean of Lifelong Learning in the University of Florida College of Pharmacy. His research interests include the search for new treatment options from natural products for central nervous system and gastrointestinal diseases such as anxiety and depressive disorders, as well as irritable bowel syndrome and cancers of the gastrointestinal tract. He served as President-Elect of the American College of Clinical Pharmacology from 2022 to 2024 and as President from 2024 to 2026. He received the Elizabeth Wood Dunlevie Honors Term Professorship Award from the University of Florida Honors Program for 2025–2026.